Catalyst Wire Dossier Catalyst Wire Dossier

Emraclidine

Emraclidine · Cerevel Therapeutics
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Emraclidine, covering 2024-05-02 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia [Phase 2]

See pricing